# Regeneron Pharmaceuticals, Inc.: Form 4, filed Sep 10, 2018

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 4
- Filed: 2018-09-10
- Accepted by EDGAR: Sep 10, 2018, 17:01 ET
- Period: 2018-09-06
- Accession: 0001140361-18-038175
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000114036118038175/xslF345X03/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000114036118038175/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000114036118038175/xslF345X03/form4.xml

Filed Sep 10, 2018.
Source: SEC EDGAR, the filing index for accession 0001140361-18-038175. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.